Literature DB >> 1703080

Effects of R56865 on membrane currents in isolated ventricular cardiomyocytes of the guinea-pig.

H M Himmel1, D Wilhelm, U Ravens.   

Abstract

In isolated heart muscle, the compound R56865 (N-[1-[4-(4-fluorophenoxy)butyl]-4-piperidinyl]-N-methyl-2- benzothiazolamine) has been shown to protect against intoxication by cardiac glycosides. We studied the influence of R56865 on various membrane currents in single isolated ventricular cardiomyocytes of the guinea-pig. The sodium current, INa, was investigated at reduced extracellular Na+ (30 mM) in the presence of Cd2+ to block the calcium current, ICa, and with Cs+ substituted for K+ to reduce the K+ currents, IK. Under these conditions, R56865 concentration dependently decreased the peak INa with a half-maximum effect at about 1 microM. The steady state inactivation and normalized conductance of INa were not significantly different from the control. In 'normal' Tyrode solution, R56865 (10 microM) did not markedly reduce ICa, and did not affect the quasi steady state IK, which was taken as an index of K+ conductance. We conclude that R56865 possesses Na+ channel-blocking properties, whereas ICa and membrane K+ conductance were not influenced.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1703080     DOI: 10.1016/0014-2999(90)90010-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Effects of class III antiarrhythmic drugs on the Na(+)-activated K+ channels in guinea-pig ventricular cells.

Authors:  K Mori; T Saito; Y Masuda; H Nakaya
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

2.  Characterization of the interaction of R 56865 with cardiac Na- and L-type Ca channels.

Authors:  D Wilhelm; H Himmel; U Ravens; T Peters
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

3.  R56865 inhibits catecholamine release from bovine chromaffin cells by blocking calcium channels.

Authors:  L Garcez-Do-Carmo; A Albillos; A R Artalejo; M T de la Fuente; M G López; L Gandía; P Michelena; A G García
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

4.  Effects of R 56865 on postischemic ventricular function in isolated rat working heart preparations obtained from healthy, diabetic and hypertensive animals.

Authors:  A J Pijl; M G Hendriks; K L Kam; M Paffendorf; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

5.  Effect of R56865 on cardiac sarcoplasmic reticulum function and its role as an antagonist of digoxin at the sarcoplasmic reticulum calcium release channel.

Authors:  S J McGarry; E Scheufler; A J Williams
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.